Source: GWASCAT
Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
1-acylglycerol-3-phosphate O-acyltransferase 5 | 7.1E-06 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2018 | 2018 | ||||||||||
|
2'-5'-oligoadenylate synthetase 3 | 0.608 | 0.615 | 2.0E-33 |
|
phenotype | 0.100 | None | 1.000 | 2 | 1 | 2019 | 2020 | ||||||||
|
acid phosphatase 1 | 0.566 | 0.731 | 1.8E-08 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||||
|
acid phosphatase 2, lysosomal | 0.780 | 0.346 | 6.2E-05 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
acyl-CoA oxidase like | 0.674 | 0.577 | 5.2E-15 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
acylphosphatase 2 | 0.659 | 0.577 | 6.5E-05 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||||
|
adenosine monophosphate deaminase 3 | 0.743 | 0.385 | 1.1E-12 |
|
phenotype | 0.100 | None | 1.000 | 2 | 1 | 2010 | 2013 | ||||||||
|
adenylate cyclase 5 | 0.617 | 0.577 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2018 | 2018 | ||||||||
|
ADP ribosylation factor like GTPase 15 | 0.769 | 0.346 | 9.4E-04 |
|
phenotype | 0.100 | None | 1.000 | 5 | 3 | 2010 | 2018 | ||||||||
|
AF4/FMR2 family member 1 | 0.659 | 0.423 | 0.71 |
|
phenotype | 0.100 | None | 1.000 | 3 | 4 | 2017 | 2019 | ||||||||
|
AKT serine/threonine kinase 1 | 0.311 | 0.962 | 0.98 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
aldehyde dehydrogenase 1 family member A2 | 0.578 | 0.692 | 0.36 |
|
phenotype | 0.100 | None | 1.000 | 34 | 26 | 2008 | 2019 | ||||||||
|
amine oxidase copper containing 1 | 0.628 | 0.769 | 6.7E-08 |
|
phenotype | 0.100 | None | 1.000 | 3 | 1 | 2013 | 2018 | ||||||||
|
angiopoietin like 4 | 0.498 | 0.731 | 2.3E-11 |
|
phenotype | 0.100 | None | 1.000 | 11 | 3 | 2010 | 2019 | ||||||||
|
angiopoietin like 8 | 0.650 | 0.577 | 6.9E-12 |
|
phenotype | 0.100 | None | 1.000 | 4 | 2 | 2013 | 2019 | ||||||||
|
ankyrin repeat and SOCS box containing 3 | 0.861 | 0.192 | 1.4E-07 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
ankyrin repeat and sterile alpha motif domain containing 3 | 0.821 | 0.192 | 1.9E-07 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||||
|
APCDD1L divergent transcript | 1.000 | 0.077 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2010 | 2010 | |||||||||
|
APOA1 antisense RNA | 0.760 | 0.269 |
|
phenotype | 0.100 | None | 1.000 | 1 | 2 | 2018 | 2018 | |||||||||
|
APOC4-APOC2 readthrough (NMD candidate) | 0.821 | 0.308 |
|
phenotype | 0.100 | None | 1.000 | 3 | 1 | 2012 | 2019 | |||||||||
|
apolipoprotein A1 | 0.429 | 0.885 | 5.5E-04 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
apolipoprotein A5 | 0.587 | 0.615 | 5.6E-10 |
|
phenotype | 0.100 | None | 1.000 | 6 | 6 | 2011 | 2019 | ||||||||
|
apolipoprotein B | 0.453 | 0.808 | 1.9E-16 |
|
phenotype | 0.100 | None | 1.000 | 7 | 7 | 2010 | 2019 | ||||||||
|
apolipoprotein C3 | 0.531 | 0.731 | 1.0E-02 |
|
phenotype | 0.100 | None | 1.000 | 4 | 2 | 2017 | 2019 | ||||||||
|
apolipoprotein C4 | 0.743 | 0.385 | 8.9E-08 |
|
phenotype | 0.100 | None | 1.000 | 3 | 1 | 2012 | 2019 |